Status:
COMPLETED
Gestational Diabetes: Insulin or Oral Hypoglycemic Agents?
Lead Sponsor:
Université de Sherbrooke
Collaborating Sponsors:
Fonds de la Recherche en Santé du Québec
Conditions:
Gestational Diabetes Mellitus
Eligibility:
FEMALE
18+ years
Phase:
PHASE3
Brief Summary
Gestational diabetes mellitus takes place in 2 steps. First, it is the consequence of insulin resistance due to the modifications of the pregnancy hormonal environment, and second, of the deficiency o...
Eligibility Criteria
Inclusion
- women,
- age ≥ 18 yrs,
- with gestational diabetes at 24-28 weeks (Canadian Diabetes Association (CDA) criteria),
- who need a pharmacological treatment following the failure of the diet and exercise,
- to understand and read French or English.
Exclusion
- known type 1 or type 2 diabetes,
- treatment interfering with glucose metabolism,
- allergies to one of the components of the treatment,
- hepatic or hematologic diseases.
Key Trial Info
Start Date :
August 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2016
Estimated Enrollment :
73 Patients enrolled
Trial Details
Trial ID
NCT01215331
Start Date
August 1 2010
End Date
May 1 2016
Last Update
May 3 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre de recherche clinique du CHUS
Sherbrooke, Quebec, Canada, J1H 5N4